BD joins effort to boost lab quality in China and India

BD Diagnostics ($BDX) will work with a major medical group to boost the quality of medical testing labs in China and India. The division of Becton Dickinson said it will collaborate with the College of American Pathologists on the project. Both organizations will offer education to boost training and awareness of global practice standards, and BD itself will manage distribution of quality assurance/proficiency testing for client labs. Item

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.